Document:

ex105.htm

Exhibit 10.5

 

 

ONCOTHYREON INC.

 

AMENDMENT TO SHASHI KARAN OFFER LETTER

 

This amendment (the “Amendment”) is made by and between Shashi Karan (“Executive”) and Oncothyreon Inc., a Delaware corporation (the “Company”
and together with the Executive hereinafter collectively referred to as the “Parties”) on December 3, 2009.

 

WITNESSETH:

 

WHEREAS, the Parties previously entered into an offer letter, dated March 24, 2008 (the “Offer Letter”); and

 

WHEREAS, the Company and Executive desire to amend certain provisions of the Offer Letter in order to provide Executive with certain Change in Control benefits;

 

NOW, THEREFORE, for good and valuable consideration, Executive and the Company agree that the Offer Letter is hereby amended as follows:

 

1.           Change in Control.  Section 12 of the Offer Letter is hereby added as follows:

 

“12.

 

Change in Control: In the event there is a “Change in Control” as defined herein and you remain employed through the date of the Change in Control, you will be entitled to the following:

 

i)           Lump sum payment of one year’s base salary, less required withholding, and

 

ii)           Lump sum payment of one year’s equivalent of performance review bonus at target, less required withholding.

 

Such payments will be made within sixty (60) days following the consummation of the Change in Control, provided that, within forty-five (45) days of the Change in Control, you have signed a separation agreement in a form reasonably satisfactory to the Company, which shall include a general release of all claims against the Company
and its affiliated entities.

 

“Change in Control” for the purpose of this agreement shall be deemed to have occurred if, on or after the date hereof (i) the board of directors of the Company passes a resolution to the effect that, for purposes of the Company’s Amended and Restated Share Option Plan, a Change in Control has occurred or (ii) any
person or any group of two or more persons acting jointly or in concert becomes the beneficial owner, directly or indirectly, or acquires the right to control or direct, twenty-five (25%) percent or more of the outstanding voting securities of the Company or any successor to the Company in any manner, including without limitation as a result of a takeover bid or an amalgamation of the Company with any other corporation or any other business combination or reorganization, and for purposes hereof “voting
security” means any security other than a debt security carrying a voting right either under all circumstances or under some circumstances that have occurred and are continuing.”

 

 

 

 

 

2.           Full Force and Effect.  To the extent not expressly amended hereby, the Offer Letter shall remain in full force and effect.

 

3.           Entire Agreement.  This Amendment and the Offer Letter constitute the full and entire understanding and agreement between the Parties with regard to the subjects hereof and thereof.  This
Amendment may be amended at any time only by mutual written agreement of the Parties.

 

4.           Counterparts.  This Amendment may be executed in counterparts, all of which together shall constitute one instrument, and each of which may be executed by less than all of the parties to this
Amendment.

 

5.           Governing Law.  This Amendment will be governed by the laws of the State of Washington (with the exception of its conflict of laws provisions).

 

IN WITNESS WHEREOF, each of the Parties has executed this Amendment, in the case of the Company by its duly authorized officer, as of the date set forth above.

 

 

	COMPANY       	ONCOTHYREON INC.	 
	 	 	 	 
	
 
	/s/ Robert Kirkman, M.D. 	 
	 	By: 	Robert Kirkman, M.D. 	 
	 	Title: 	President & Chief Executive Officer	 
	 	 	 	 
	EXECUTIVE 	SHASHI KARAN	 
	 	 	 	 
	 	/s/ Shashi KaranEX-10.1

Exhibit 10.1

Execution Copy

STOCK PURCHASE AGREEMENT

THIS STOCK PURCHASE AGREEMENT, dated as of December 1, 2009 (this “Agreement”), is by and
between ENER1, INC., a Florida corporation (the “Company”), and ITOCHU CORPORATION, a Japanese
corporation (the “Investor”).

A. The Investor wishes to purchase from the Company, and the Company wishes to sell to the
Investor, upon the terms and subject to the conditions set forth in this Agreement, the number of
shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), set forth
opposite the Investor’s name on Exhibit A.

B. The purchase price per share of Common Stock shall be equal to US$6.18. The aggregate
offering of Common Stock to the Investor shall be up to approximately US$20,000,000.

C. The Company and the Investor are executing and delivering this Agreement in reliance upon
the exemption from registration afforded by the provisions of Section 4(2) of the Securities Act of
1933 (as amended, together with the rules and regulations promulgated thereunder) (the “Securities
Act”) and Rule 506 of Regulation D (“Regulation D”), as promulgated by the Securities and Exchange
Commission (the “Commission”), pursuant to the Securities Act.

In consideration of the mutual promises made herein and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby
agree as follows:

1. TERMINOLOGY AND USAGE.

1.1 Definitions. When used herein, the terms below shall have the respective meanings
indicated:

“Affiliate” means, as to any Person (the “subject Person”), any other Person (a) that directly
or indirectly through one or more intermediaries controls or is controlled by, or is under direct
or indirect common control with the subject Person, (b) that, directly or indirectly, beneficially
owns or holds ten percent (10%) or more of any class of voting equity of the subject Person, or
(c) of which ten percent (10%) or more of the voting equity is directly or indirectly beneficially
owned or held by the subject Person. For the purposes of this definition, “control” when used with
respect to any Person means the power to direct the management and policies of such Person,
directly or indirectly, whether through the ownership of voting securities, through representation
on such Person’s board of directors or other management committee or group, by contract or
otherwise.

“Board of Directors” means the Company’s board of directors.

“Business Day” means any day other than a Saturday, a Sunday or a day on which the Principal
Market is closed or on which banks in the City of New York are required or authorized by law to be
closed.

“Closing Price” on a Trading Day means the closing sales price of the Common Stock for such
Trading Day on the Principal Market as reported by Bloomberg Financial Markets or, if Bloomberg
Financial Markets is not then reporting such prices, by a comparable reporting service of national
reputation selected by the Company and reasonably satisfactory to the Investor.  All such
determinations shall be appropriately adjusted for any stock dividend, stock split, reverse stock
split or other similar transaction during such period.

“Disclosure Documents” means all reports, schedules, registration statements and definitive
proxy statements filed by the Company with the Commission after December 31, 2008.

“Environmental Law” means any federal, state, provincial, local or foreign law, statute, code
or ordinance, principle of common law, rule or regulation, as well as any permit, order, decree,
judgment or injunction issued, promulgated, approved or entered thereunder, relating to pollution
or the protection, cleanup or restoration of the environment or natural resources, or to the public
health or safety, or otherwise governing the generation, use, handling, collection, treatment,
storage, transportation, recovery, recycling, discharge or disposal of hazardous materials.

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the
regulations and published interpretations thereunder.

“Exchange Act” means the Securities Exchange Act of 1934 (as amended, together with the rules
and regulations promulgated thereunder).

“Execution Date” means the date of this Agreement.

“GAAP” means generally accepted accounting principles, applied on a consistent basis, as set
forth in (i) opinions of the Accounting Principles Board of the American Institute of Certified
Public Accountants, (ii) statements and pronouncements of the Financial Accounting Standards Board,
(iii) interpretations of the Commission and the staff of the Commission, and (iv) in such other
statements by such other Person as have been approved by a significant segment of the accounting
profession, in each case as are in effect as of the date of determination. Accounting principles
are applied on a “consistent basis” when the accounting principles applied in a current period are
comparable in all material respects to those accounting principles applied in a preceding period,
except as may be expressly stated in the related notes thereto.

“Governmental Authority” means any nation or government, any state, provincial or political
subdivision thereof and any entity exercising executive, legislative, judicial, regulatory or
administrative functions of or pertaining to government, including, without limitation, any stock
exchange, securities market, self-regulatory organization and the Financial Industry Regulatory
Authority, Inc.

“Governmental Requirement” means any law, statute, code, ordinance, order, rule, regulation,
judgment, decree, injunction, franchise, license or other directive or requirement of any
Governmental Authority.

“Intellectual Property” means any U.S. or foreign patents, patent rights, patent applications,
trademarks, trade names, service marks, brand names, logos and other trade designations (including
unregistered names and marks), trademark and service mark registrations and applications,
copyrights and copyright registrations and applications, inventions, invention disclosures,
protected formulae, formulations, processes, methods, trade secrets, computer software, computer
programs and source codes, manufacturing research and similar technical information, engineering
know-how, customer and supplier information, assembly and test data drawings or royalty rights.

“Knowledge” means, as to the Company, the knowledge of the Company after having made all
reasonable inquiries to obtain and/or verify the information, fact(s) and/or circumstance(s).

“Material Adverse Effect” means a material and adverse effect on (a) the consolidated
business, assets, results of operations or financial condition of the Company and its subsidiaries
taken as a whole, (b) the ability of the Company to perform its material obligations under this
Agreement or (c) the material rights and benefits to which the Investor is entitled under this
Agreement, except that any of the following, either alone or in combination, shall not be deemed a
Material Adverse Effect: (i) effects caused by changes or circumstances affecting general or
political conditions, domestic or foreign securities, or credit or financial markets, (ii) effects
caused by material changes or circumstances that are generally applicable to the industry in which
the Company and its subsidiaries operate, (iii) effects resulting from or relating to the material
announcement or disclosure of the sale of the Shares or other transactions contemplated by this
Agreement, or (iv) any acts of terrorism or war, except, in each case to the extent that such
effect has a materially disproportionate effect on Company and its subsidiaries, taken as whole, as
compared to other similarly situated Persons that operate in the industry in which Company and its
subsidiaries operate.

“Person” means any individual, corporation, trust, association, company, partnership, joint
venture, limited liability company, joint stock company, Governmental Authority or other entity.

“Principal Market” means the Nasdaq Global Market or such other principal exchange, market or
quotation system on which the Common Stock is listed, traded or quoted.

“Property” means property and/or assets of all kinds, whether real, personal or mixed,
tangible or intangible (including, without limitation, all rights relating thereto).

“Rule 144” means Rule 144 (as may be amended from time to time) promulgated pursuant to the
Securities Act or any successor provision.

“Trading Day” means any day on which shares of Common Stock are purchased and sold on the
Principal Market.

1.2 Definitional Cross-References. Each of the following additional terms shall have
the meaning defined for such term in the Section set forth opposite such term below:

	 	 	 
	“Agreement”

	 	Preamble
	“Closing”

	 	Section 2.1
	“Closing Date”

	 	Section 2.1
	“Commission”

	 	Recitals
	“Common Stock”

	 	Recitals
	“Company”

	 	Preamble
	“Investor”

	 	Preamble
	“Investor Party”

	 	Section 5.4
	“Regulation D”

	 	Recitals
	“Securities Act”

	 	Recitals
	“Shares”

	 	Section 2.1
	“Short Sales”

	 	Section 3.11

1.3 Other Definitional Provisions. All definitions contained in this Agreement are
equally applicable to the singular and plural forms of the terms defined. The words “hereof”,
“herein” and “hereunder” and words of similar import contained in this Agreement refer to this
Agreement as a whole and not to any particular provision of this Agreement.

2. PURCHASE AND SALE OF COMMON STOCK.

2.1 Closing. Upon the terms and subject to the satisfaction or waiver of the
conditions set forth in Section 2.2, the Company agrees to sell to the Investor, and the Investor
agrees to purchase from the Company, the number of shares of Common Stock set forth opposite the
Investor’s name on Exhibit A. The shares of Common Stock to be purchased by the Investor hereunder
are sometimes referred to herein as the “Shares”. The purchase price per share of Common Stock
shall be US$6.18. The date on which the closing (the “Closing”) occurs is hereinafter referred to
as the “Closing Date”. The Closing shall be deemed to occur at the offices of Mazzeo Song &
Bradham LLP, 708 Third Avenue, 19th Floor, New York, New York 10017, or at such other
locations, remotely by facsimile transmission or other electronic means, as the parties may
mutually agree, when the conditions to the Closing specified in Section 2.2 shall have all been
satisfied or waived as specified therein.

2.2 Conditions to Closing.

(a) Conditions to the Investor’s Obligations at the Closing. The Investor’s
obligation to effect the Closing, including, without limitation, its obligation to purchase the
Shares at the Closing, is conditioned upon the fulfillment (or waiver in a written form by the
Investor in its sole and absolute discretion) of each of the following events as of the Closing
Date:

	 	(i)	 	the representations and warranties of the
Company set forth in this Agreement shall be true and correct in all
material respects as of the Closing Date as if made on such date
(except that, to the extent that any such representation or warranty
relates to a particular date, such representation or warranty shall be
true and correct in all material respects as of that particular date);

	 	(ii)	 	the Company shall have complied with or
performed all of the agreements, obligations and conditions set forth
in this Agreement that are required to be complied with or performed by
the Company on or before the Closing;

	 	(iii)	 	the Company shall have delivered to the
Investor a reasonably acceptable opinion of legal counsel dated as of
the Closing Date;

	 	(iv)	 	the Company shall have delivered to the
Investor (i) a certificate, signed by the Secretary or an Assistant
Secretary of the Company, attaching (x) the articles of incorporation
and by-laws of the Company, and (y) resolutions passed by the Board of
Directors authorizing the transactions contemplated by this Agreement,
and (ii) a recently dated good standing certificate or similar document
verifying that the Company is validly existing and in good standing
under the laws of the State of Florida; and

	 	(v)	 	there shall be no injunction, restraining order
or decree of any nature of any court or Governmental Authority of
competent jurisdiction that is in effect that restrains or prohibits
the consummation of the transactions contemplated hereby.

(b) Conditions to Company’s Obligations at the Closing. The Company’s obligations to
effect the Closing, including, without limitation, its obligation to issue the Shares to the
Investor at the Closing, are conditioned upon the fulfillment (or waiver by the Company in its sole
and absolute discretion) of each of the following events as of the Closing Date:

	 	(i)	 	the representations and warranties of the
Investor set forth in this Agreement shall be true and correct in all
material respects as of the Closing Date as if made on such date
(except that, to the extent that any such representation or warranty
relates to a particular date, such representation or warranty shall be
true and correct in all material respects as of that date);

	 	(ii)	 	the Investor shall have complied with or
performed all of the agreements, obligations and conditions set forth
in this Agreement that are required to be complied with or performed
by the Investor on or before the Closing;

	 	(iii)	 	there shall be no injunction, restraining
order or decree of any nature of any court or Governmental Authority of
competent jurisdiction that is in effect that restrains or prohibits
the consummation of the transactions contemplated hereby; and

	 	(iv)	 	the Investor shall have tendered to the Company
the purchase price for the Shares by wire transfer of immediately
available funds.

3. REPRESENTATIONS AND WARRANTIES OF THE INVESTOR.

The Investor hereby represents and warrants to the Company and agrees with the Company that,
as of the Execution Date:

3.1 Authorization; Enforceability. The Investor is duly organized, validly existing
and in good standing under the laws of its formation and has the requisite corporate power and
authority to purchase the Shares to be purchased by it hereunder and to execute and deliver this
Agreement and no further consent is required by the Investor, its board of directors, stockholders,
managers, members or partners. This Agreement constitutes the Investor’s valid and legally binding
obligation, enforceable in accordance with its terms, subject to (i) applicable bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium or other similar laws of general
application relating to or affecting the enforcement of creditors’ rights generally, (ii) general
principles of equity, and (iii) applicable laws limiting the enforcement of indemnification and
contribution provisions or waivers of the right to a trial by jury.

3.2 Accredited Investor. The Investor (i) is an “accredited investor” as that term is
defined in Rule 501 of Regulation D, (ii) was not formed or organized for the specific purpose of
making an investment in the Company, and (iii) is acquiring the Shares solely for its own account
and not with a present view to the public resale or distribution of all or any part thereof, except
pursuant to sales that are registered under, or exempt from the registration requirements of, the
Securities Act; provided, however, that in making such representation, the Investor does not agree
to hold the Shares for any minimum or specific term and reserves the right to sell, transfer or
otherwise dispose of the Shares at any time in accordance with the provisions of this Agreement and
with federal and state securities laws applicable to such sale, transfer or disposition. The
Investor can bear the economic risk of a total loss of its investment in the Shares and has such
knowledge and experience in business and financial matters so as to enable it to understand the
risks of and form an investment decision with respect to its investment in the Shares.

3.3 Information. The Investor acknowledges that it has reviewed the Disclosure
Documents and has been afforded: (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, the Company and its representatives concerning the terms
and conditions of the offering of the Shares and the merits and risks of investing in the Shares;
(ii) access to information (other than material non-public information) about the Company and its
financial condition, results of operations, business, properties, management and prospects
sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such
additional information that the Company possesses or can acquire without unreasonable effort or
expense that is necessary to make an informed investment decision with respect to the investment.
The Investor acknowledges that it is not relying upon, and has not relied upon, any statement,
representation or warranty made by any Person, except for the statements, representations and
warranties made by the Company and contained in Section 4 of this Agreement and the Disclosure
Documents.

3.4 Limitations on Disposition. The Investor acknowledges that the Shares have not
been and are not being registered under the Securities Act and may not be transferred or resold
without registration under the Securities Act or unless pursuant to an exemption therefrom.

3.5 Legend. The Investor understands that the certificates representing the Shares
may bear at issuance a restrictive legend in substantially the following form:

“The securities represented by this certificate have not been registered
under the Securities Act of 1933, as amended (the “Securities Act”), or any
state securities laws, and may not be offered for sale or sold unless a
registration statement under the Securities Act and applicable state
securities laws shall have become effective with respect thereto, or an
exemption from registration under the Securities Act and applicable state
securities laws is available in connection with such offer or sale.”

Notwithstanding the foregoing, it is agreed that, as long as (a) the resale or transfer of any of
the Shares is registered pursuant to an effective registration statement, or (b) such Shares have
been sold pursuant to Rule 144, subject to receipt by the Company of customary documentation and a
legal opinions reasonably acceptable to the Company in connection therewith, such Shares shall be
issued without any legend or other restrictive language and, with respect to Shares upon which such
legend is stamped, the Company shall issue new certificates without such legend to the Investor (or
its transferee) upon request. The Company shall execute and deliver written instructions to the
transfer agent for its Common Stock as may be necessary to satisfy any request by the Investor for
removal of such legends no later than the close of business on the third Business Day following the
receipt of the request from the Investor to the extent such legends may be removed in accordance
with this Section 3.5.

3.6 Reliance on Exemptions. The Investor understands that the Shares are being
offered and sold to it in reliance upon specific exemptions from the registration requirements of
federal and state securities laws and that the Company is relying upon the truth and accuracy of
the representations and warranties of the Investor set forth in this Section 3 in order to
determine the availability of such exemptions and the eligibility of the Investor to acquire the
Shares. The Investor acknowledges that it is not purchasing the Shares based upon any
advertisement in any publication of general circulation. The Investor is relying on the
representations, acknowledgements and agreements made by the Company in Section 4 and elsewhere in
this Agreement in making investing, trading and/or other decisions concerning the Company’s
securities.

3.7 Non-Affiliate Status; Common Stock Ownership. The Investor is not an Affiliate of
the Company and is not acting in association or concert with any other Person in regard to its
purchase of the Shares or otherwise in respect of the Company. The Investor’s investment in the
Shares is not for the purpose of acquiring, directly or indirectly, control of, and it has no
intent to acquire or exercise control of, the Company or to influence the decisions or policies of
the Board of Directors.

3.8 Fees. The Investor has not agreed to pay any compensation or other fee, cost or
related expenditure to any underwriter, broker, agent or other representative in connection with
the transactions contemplated hereby.

3.9 No Conflicts. The execution and performance of this Agreement do not conflict in
any material respect with any agreement to which the Investor is a party or is bound, any court
order or judgment applicable to the Investor, or the constituent documents of the Investor.

3.10 No Governmental Review. The Investor understands that no federal or state agency
or any other Governmental Authority has passed on or made any recommendation or endorsement of the
Shares or the fairness or suitability of an investment in the Shares nor have such authorities
passed upon the accuracy of any information provided to the Investor or made any findings or
determinations as to the merits of the offering of the Shares.

3.11 Certain Trading Activities. The Investor has not, in violation of the securities
laws, directly or indirectly, nor has any Person acting on behalf of or pursuant to any
understanding with the Investor, engaged in any transactions in the securities of the Company
(including, without limitations, any Short Sales, “locking-up,” borrowing or hedging activities
involving the Company’s securities) since the time that the Investor and the Company were first in
contact regarding the investment in the Company contemplated by this Agreement. The Investor
covenants that neither it nor any Person acting on its behalf or pursuant to any understanding with
it will engage, directly or indirectly, in any transactions in the securities of the Company
(including, without limitation, any Short Sales, “locking-up,” borrowing or hedging activities
involving the Company’s securities) prior to the time that the transactions contemplated by this
Agreement are publicly disclosed pursuant to Section 5.1(c). “Short Sales” include, without
limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the
Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options,
puts, calls, short sales, swaps, derivatives and similar arrangements (including on a total return
basis), and sales and other transactions through non-U.S. broker-dealers or foreign regulated
brokers.

4. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company hereby represents and
warrants to the Investor and agrees with the Investor that, as of the Execution Date:

4.1 Organization, Good Standing and Qualification. The Company is duly organized,
validly existing and in good standing under the laws of the State of Florida and has all requisite
power and authority to carry on its business as currently conducted. The Company is duly qualified
to transact business and is in good standing in each jurisdiction in which it conducts business.

4.2 Authorization; Consents. The Company has the requisite corporate power and
authority to enter into and perform its obligations under this Agreement, including, without
limitation, the issuance and sale of the Shares to the Investor in accordance with the terms hereof
and thereof. All corporate action on the part of the Company necessary for the authorization,
execution and delivery of, and the performance by the Company of its obligations under, this
Agreement have been taken, and no further consent or authorization of any Person (including,
without limitation, any of the Board of Directors, stockholders, managers or any Governmental
Authority) is required under any organizational document, contract, Governmental Requirement or
otherwise. The Board of Directors has taken all action required by applicable law and the
organizational documents of the Company to be taken by it to duly authorize the execution of and
performance of the Company’s obligations under this Agreement.

4.3 Enforcement. This Agreement has been duly executed and delivered by the Company.
This Agreement constitutes the valid and legally binding obligation of the Company, enforceable
against the Company in accordance with its terms, subject to (i) applicable bankruptcy, insolvency,
fraudulent transfer, moratorium, reorganization or other similar laws of general application
relating to or affecting the enforcement of creditors’ rights generally, (ii) general principles of
equity, and (iii) applicable laws limiting the enforcement of indemnification and contribution
provision or waivers of the right to a trial by jury.

4.4 Disclosure Documents; Agreements; Financial Statements; Other Information. The
Company has filed with the Commission on a timely basis or has received a valid extension to such
time of filing of all Disclosure Documents that the Company was required to file with the
Commission. The Company is not aware of any event occurring on or prior to the Execution Date
(other than the transactions effected hereby) that would require the filing of, or with respect to
which the Company intends to file, a Form 8-K after the Execution Date. Each Disclosure Document,
as of the date of the filing thereof with the Commission (or if amended or superseded by a filing
prior to the Execution Date, then on the date of such amending or superseding filing), complied in
all material respects with the requirements of the Securities Act or Exchange Act. All documents
required to be filed as exhibits to the Disclosure Documents have been filed as required or will be
filed with the next periodic report of the Company required to be filed with the Commission as
permitted under the Exchange Act or the Securities Act, as applicable. Except as set forth in the
Disclosure Documents, the Company has no liabilities, contingent or otherwise, other than
liabilities incurred in the ordinary course of business which, individually or in the aggregate,
are not material to the consolidated business or financial condition of the Company. As of their
respective dates, the financial statements of the Company included in the Disclosure Documents
complied as to form in all material respects with applicable accounting requirements and the
published rules and regulations of the Commission with respect thereto as in effect at the time of
filing (or, if amended or superseded by a filing prior to the Closing Date, then as of the date of
such filing). Such financial statements have been prepared in accordance with GAAP consistently
applied at the times and during the periods involved (except (i) as may be otherwise indicated in
such financial statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be condensed or summary statements) and
fairly present in all material respects the financial position of the Company as of the dates
thereof and the results of its operations and cash flows for the periods then ended (subject, in
the case of unaudited statements, to normal year-end adjustments).

4.5 Due Authorization; Valid Issuance. The Shares are duly authorized and, when
issued, sold and delivered in compliance with the terms of this Agreement, shall be duly and
validly issued, free and clear of any liens imposed by or through the Company. Assuming the
accuracy of each Investor’s representations contained herein, the issuance and sale of the Shares
under this Agreement shall be effected in compliance with all applicable federal and state
securities laws.

4.6 No Conflict. The Company is not in violation of any provisions of its articles of
incorporation, bylaws or any other organizational document. The Company is not in violation of or
in default (and no event has occurred which, with notice or lapse of time or both, would constitute
a default) under any provision of any instrument or contract to which it is a party or by which it
or any of its Property is bound, or in violation of any provision of any Governmental Requirement
applicable to the Company, except for any violation or default that has not had or would not
reasonably be expected to have a Material Adverse Effect. The (i) execution, delivery and
performance of this Agreement and (ii) consummation by the Company of the transactions contemplated
hereby shall not result in any violation of any provisions of the Company’s articles of
incorporation, bylaws or any other organizational document, or in a default under any provision of
any material instrument or agreement to which the Company is a party or by which it or any of its
Property is bound, or in violation of any court order or judgment applicable to the Company or
provision of any Governmental Requirement applicable to the Company or be in conflict with or
constitute, with or without the passage of time and giving of notice, a default under any such
instrument or agreement.

4.7 Financial Condition. The financial condition of the Company is, in all material
respects, as described in the Disclosure Documents, except for changes in the ordinary course of
business and normal year-end adjustments that are not, in the aggregate, materially adverse to the
consolidated business or financial condition of the Company. There has been no (i) material
adverse change to the business, assets, financial condition or results of operations of the Company
since the date of the Company’s most recent financial statements contained in the Disclosure
Documents, or (ii) material change by the Company in its accounting principles, policies and
methods except as required by changes in GAAP.

4.8 Litigation. There is no material claim, litigation or administrative proceeding
pending, or, to the Company’s Knowledge, threatened or contemplated, against the Company, or
against any officer, director or employee of the Company in connection with such Person’s
employment therewith. The Company is not a party to or subject to the provisions of any order,
writ, injunction, judgment or decree of any court or Governmental Authority which has had or would
reasonably be expected (in the judgment of the Company) to have a Material Adverse Effect.

4.9 Intellectual Property. To the Knowledge of the Company, the Company and its
subsidiaries own, free and clear of claims or rights of any other Person, with full right to use,
sell, license, sublicense, dispose of, and bring actions for infringement of, or, to the Knowledge
of the Company, has acquired licenses or other rights to use, all Intellectual Property necessary
for the conduct of their business as presently conducted, other than with respect to software which
is generally commercially available and not used or incorporated into the Company’s or its
subsidiaries’ products and open source software which may be subject to one or more “general
public” licenses or where the absence of such rights do not have or result in a Material Adverse
Effect. The business of each of the Company and its subsidiaries as presently conducted and the
production, marketing, licensing, use and servicing of any products or services of the Company and
its subsidiaries do not, to the Knowledge of the Company, infringe or conflict with any patent,
trademark, copyright, or trade secret rights of any third parties or any other Intellectual
Property of any third parties in any material respect. Neither the Company nor its subsidiaries
has received written notice from any third party asserting that any Intellectual Property owned or
licensed by the Company or its subsidiaries, or which the Company or its subsidiaries otherwise has
the right to use, is invalid or unenforceable by the Company or its subsidiaries and, to the
Company’s Knowledge, there is no valid basis for any such claim (whether or not pending or
threatened). The Company and its subsidiaries have taken measures in accordance with commercially
reasonable business practice to establish and preserve their ownership in their owned Intellectual
Property and to keep confidential all material technical information developed by or belonging to
the Company or its subsidiaries which has not been patented or copyrighted.

4.10 Solicitation; Other Issuances of Securities. Neither the Company nor any of its
Affiliates, nor any Person acting on its or their behalf, (i) has engaged in any form of general
solicitation or general advertising (within the meaning of Regulation D) in connection with the
offer or sale of the Shares, (ii) has, directly or indirectly, made any offers or sales of any
security or the right to purchase any security, or solicited any offers to buy any security or any
such right, under circumstances that would require registration of the Shares under the Securities
Act, or (iii) has issued any shares of Common Stock or shares of any series of preferred stock or
other securities or instruments convertible into, exchangeable for or otherwise entitling the
holder thereof to acquire shares of Common Stock which would be integrated with the sale of the
Shares to the Investor for purposes of the Securities Act or of any applicable stockholder approval
provisions nor shall the Company or any Affiliate take any action or steps that would cause the
offering of the Shares to be so integrated with other offerings.

4.11 Fees. The Company is not obligated to pay any brokers, finders or financial
advisory fees or commissions to any underwriter, broker, agent or other representative in
connection with the transactions contemplated hereby. The Company shall indemnify and hold
harmless each Investor from and against any claim by any Person alleging that the Investor is
obligated to pay any such compensation, fee, cost or related expenditure in connection with the
transactions contemplated hereby.

4.12 Executive Officers. The “executive officers” (as defined in Rule 501(f) of the
Securities Act) of the Company are currently serving in the capacity described in the Disclosure
Documents. The Company has no Knowledge of any fact or circumstance (including, without
limitation, (i) the terms of any agreement to which such person is a party or any litigation in
which such person is or may become involved and (ii) any illness or medical condition that could
reasonably be expected to result in the disability or incapacity of such person) that would limit
or prevent any such person from serving in such capacity on a full-time basis in the reasonably
foreseeable future, or of any intention on the part of any such person to limit or terminate his or
her employment with the Company.

4.13 Labor Matters. There is no strike, labor dispute or union organization
activities pending or, to the Knowledge of the Company, threatened between the Company and their
respective employees. No employees of the Company belong to any union or collective bargaining
unit. The Company has complied with all applicable federal and state equal opportunity and other
laws related to employment.

4.14 Environment. The Company is not subject to any liabilities under any
Environmental Law, nor, to the Company’s Knowledge, do any factors exist that are reasonably likely
to give rise to any such liability, affecting any of the properties owned or leased by the Company.
The Company has not violated any Environmental Law applicable to it now or previously in effect.

4.15 ERISA. The Company is in compliance with the presently applicable provisions of
ERISA and the United States Internal Revenue Code of 1986, as amended, with respect to each pension
plan maintained or contributed to by the Company, or pursuant to which the Company has any
obligations, except in any such case for any such matters that, individually or in the aggregate,
have not had, and would not reasonably be expected to have, a Material Adverse Effect.

4.16 Insurance. The Company maintains insurance for itself in such amounts and
covering such losses and risks as are reasonably sufficient and customary in the businesses and
location in which the Company is engaged. As of the date hereof, no notice of cancellation has
been received for any of such policies and the Company is in compliance in with all of the terms
and conditions thereof. The Company has no reason to believe that it shall not be able to renew
its existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue to conduct its business as currently
conducted without a significant increase in cost. Without limiting the generality of the foregoing,
the Company maintains director’s and officer’s insurance in such amounts and covering such losses
and risks that are customary for businesses that are reasonably comparable to the Company.

4.17 Property. The Company does not own any real property. The Company has good and
marketable title to all personal Property owned by it. Any Property held under lease by the
Company is held by it under valid, subsisting and enforceable leases with such exceptions as are
not material and do not interfere with the use made or proposed to be made of such Property by the
Company.

4.18 Regulatory Permits. The Company possesses all certificates, authorizations and
permits issued by the appropriate federal, state or foreign regulatory authorities necessary to
conduct its business as presently conducted and the Company has not received any notice of
proceedings relating to the revocation or modification of any such certificate, authorization or
permit.

4.19 Transfer Taxes. No stock transfer or other taxes (other than income or similar
taxes) are required to be paid in connection with the issuance and sale of any of the Shares, other
than such taxes for which the Company has established appropriate reserves and intends to pay when
and as such taxes are due.

4.20 Sarbanes-Oxley Act; Internal Controls and Procedures. To the Company’s
Knowledge, the Company is in compliance with any and all applicable requirements of the
Sarbanes-Oxley Act of 2002, as amended, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof. The Company
maintains internal accounting controls, policies and procedures reasonably designed to provide
reasonable assurance that (i) all transactions to which the Company is a party or by which its
properties are bound are effected by a duly authorized employee or agent of the Company, supervised
by and acting within the scope of the authority granted by the Company’s senior management; (ii)
the recorded accounting of the Company’s consolidated assets is compared with existing assets at
regular intervals; and (iii) all transactions to which the Company is a party, or by which its
properties are bound, are recorded (and such records maintained) in accordance with all
Governmental Requirements and as may be necessary or appropriate to ensure that the financial
statements of the Company are prepared in accordance with GAAP.

4.21 Customers and Suppliers. The relationships of the Company with its customers and
suppliers are maintained on commercially reasonable terms. To the Company’s Knowledge, no customer
or supplier of the Company has any plan or intention to terminate its agreement with the Company,
which termination would reasonably be expected to have a Material Adverse Effect.

4.22 Exchange Act Registration; Principal Market. The Company’s Common Stock is
registered pursuant to Section 12(g) of the Exchange Act and is quoted on the Nasdaq Global Market.
The Company currently meets the continuing eligibility requirements for quotation on the Nasdaq
Global Market and has not received any notice from such service that it may not currently satisfy
such requirements or that such continued quotation is in any way threatened. The Company has taken
no action designed to, or which, to the Knowledge of the Company, may have the effect of,
terminating the registration of the Common Stock under the Exchange Act or qualification to have
the Common Stock quoted on the Nasdaq Global Market.

4.23 Disclosure. The representations, warranties and written statements contained in
this Agreement and in the certificates, exhibits and schedules delivered by the Company to the
Investor pursuant to this Agreement, do not contain any untrue statement of a material fact, and do
not omit to state a material fact required to be stated therein or necessary in order to make such
representations, warranties or statements not misleading in light of the circumstances under which
they were made.

5. COVENANTS AND AGREEMENTS.

5.1 Public Disclosure by the Company. The Company shall: (i) on or prior to 5:00
p.m. (eastern time) on the fourth Business Day following the Execution Date, issue a press release
disclosing the material terms of this Agreement and the transactions contemplated hereby, and (ii)
on or prior to 5:30 p.m. (eastern time) on the fourth Business Day following the Execution Date,
file with the Commission a Current Report on Form 8-K disclosing the material terms of this
Agreement and the transactions contemplated hereby; provided, however, that counsel to the Investor
shall have a reasonable opportunity to review and comment on any such press release or Form 8-K
prior to the issuance or filing thereof.

5.2 Use of Proceeds. The Company shall use the proceeds from the sale of the Shares
for its ordinary course of business operations and working capital purposes.

5.3 Use of Investor’s Name. Except as may be required by applicable law and/or this
Agreement, the Company shall not use, directly or indirectly, the Investor’s name or the name of
any of its Affiliates in any advertisement, announcement, press release or other similar
communication unless it has received the prior written consent of the Investor for the specific use
contemplated or as otherwise required by applicable law or regulation.

5.4 Indemnification of the Investor. The Company shall indemnify and hold the
Investor and its directors, officers, shareholders, employees and agents (each, an “Investor
Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages,
costs and expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys’ fees and costs of investigation that any such Investor Party may suffer or
incur as a result of or relating to any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement. If any action shall be brought against any
Investor Party in respect of which indemnity may be sought pursuant to this Agreement, such
Investor Party shall promptly notify the Company in writing of such action and the facts related
thereto, and the Company shall have the right to assume the defense thereof with counsel of its own
choosing. Any Investor Party shall have the right to employ separate counsel in any such action
and participate in the defense thereof, but the fees and expenses of such counsel shall be at the
expense of such Investor Party except to the extent that (i) the employment thereof has been
specifically authorized by the Company in writing (it being expressly understood by the parties
that nothing in this Agreement shall be construed as granting such authorization), (ii) the Company
has failed after a reasonable period of time following such Investor Party’s written request that
it do so, to assume such defense and to employ counsel or (iii) in such action there is, in the
reasonable opinion of such separate counsel, a conflict on any material issue between the position
of the Company and the position of such Investor Party. The Company shall not be liable to any
Investor Party under this Agreement (x) for any settlement by an Investor Party effected without
the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or (y) to
the extent, but only to the extent that a loss, claim, damage or liability is attributable to such
Investor Party’s wrongful actions or omissions, or gross negligence or to such Investor Party’s
breach of any of the representations, warranties, covenants or agreements made by the Investor in
this Agreement.

5.5 Limitations on Disposition. The Investor shall not sell, transfer, assign or
dispose of any Shares, unless:

(a) there is then in effect an effective registration statement under the Securities Act
covering such proposed disposition and such disposition is made in accordance with such
registration statement; or

(b) the Investor has notified the Company in writing of any such disposition, and furnished
the Company with an opinion of counsel, reasonably satisfactory to the Company, that such
disposition shall not require registration of such Shares under the Securities Act; provided,
however, that no such opinion of counsel shall be required (i) if the sale, transfer, assignment or
disposition is made to an Affiliate of the Investor, (ii) if the sale, transfer, assignment or
disposition is made pursuant to Rule 144 and the Investor provides the Company with evidence
reasonably satisfactory to the Company that the proposed transaction satisfies the requirements of
Rule 144, or (iii) if in connection with a bona fide pledge or hypothecation of any Shares under a
margin arrangement with a broker-dealer or other financial institution or the sale of any such
Shares by such broker-dealer or other financial institution following the Investor’s default under
such margin arrangement.

In the event the Investor desires to sell, transfer, assign or dispose of any Shares after holding
such Shares for not less than six months, the Company shall use its reasonable best efforts to
ensure that the Investor is able to effectuate such proposed sale, transfer, assignment or
disposition in compliance with all applicable Governmental Requirements.

	6.	 	MISCELLANEOUS.

6.1 Survival; Severability. The representations, warranties, covenants and
indemnities made by the parties herein shall survive the Closing notwithstanding any due diligence
investigation made by or on behalf of the party seeking to rely thereon. In the event that any
provision of this Agreement becomes or is declared by a court of competent jurisdiction to be
illegal, unenforceable or void, this Agreement shall continue in full force and effect without said
provision; provided that in such case the parties shall negotiate in good faith to replace such
provision with a new provision which is not illegal, unenforceable or void, as long as such new
provision does not materially change the economic benefits of this Agreement to the parties.

6.2 Successors and Assigns. The terms and conditions of this Agreement shall inure to
the benefit of and be binding upon the respective successors and permitted assigns of the parties.
Nothing in this Agreement, express or implied, is intended to confer upon any party other than the
parties hereto or their respective successors and permitted assigns any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as expressly provided in
this Agreement. The Investor may assign its rights and obligations hereunder in connection with any
private sale of the Shares in accordance with the terms hereof, as long as, as a condition
precedent to such transfer, the transferee executes an acknowledgment agreeing to be bound by the
applicable provisions of this Agreement, in which case the term “Investor” shall be deemed to refer
to such transferee as though such transferee were an original signatory hereto, and such assignment
complies with applicable Governmental Requirements. The Company may not assign its rights or
obligations under this Agreement.

6.3 No Reliance. Each party acknowledges that (i) it has such knowledge in business
and financial matters as to be fully capable of evaluating this Agreement and the transactions
contemplated hereby, (ii) it is not relying on any advice or representation of any other party in
connection with entering into this Agreement or such transactions (other than the representations
made in this Agreement), (iii) it has not received from any other party any assurance or guarantee
as to the merits (whether legal, regulatory, tax, financial or otherwise) of entering into this
Agreement or the performance of its obligations hereunder, and (iv) it has consulted with its own
legal, regulatory, tax, business, investment, financial and accounting advisors to the extent that
it has deemed necessary, and has entered into this Agreement based on its own independent judgment
and, if applicable, on the advice of such advisors, and not on any view (whether written or oral)
expressed by any other party.

6.4 Governing Law; Jurisdiction; Waiver of Jury Trial.

(a) This Agreement shall be governed by and construed under the laws of the State of New York
applicable to contracts made and to be performed entirely within the State of New York. Each party
hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in
the City and County of New York for the adjudication of any dispute hereunder or in connection
herewith or therewith or with any transaction contemplated hereby or thereby, and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it
is not personally subject to the jurisdiction of any such court, that such suit, action or
proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by mailing a copy thereof to such party
at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner permitted by law.

(b) EACH PARTY TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY DISPUTE OR CONTROVERSY THAT
MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND,
THEREFORE, EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE
TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING
TO THIS AGREEMENT, OR THE BREACH, TERMINATION OR VALIDITY OF THIS AGREEMENT, OR THE TRANSACTIONS
CONTEMPLATED HEREBY. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (I) NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT
SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)
EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (III) EACH SUCH
PARTY MAKES THIS WAIVER VOLUNTARILY, AND (IV) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6.4(b).

6.5 Counterparts. This Agreement may be executed in any number of counterparts, each
of which shall be deemed an original, and all of which together shall constitute one and the same
instrument. This Agreement may be executed and delivered by e-mail or facsimile transmission.

6.6 Headings. The headings used in this Agreement are used for convenience only and
are not to be considered in construing or interpreting this Agreement.

6.7 Notices. Any notice, demand or request required or permitted to be given by the
Company or the Investor pursuant to the terms of this Agreement shall be in writing and shall be
deemed delivered (i) when delivered personally or by verifiable facsimile receipt, unless such
delivery is made on a day that is not a Business Day, in which case such delivery will be deemed to
be made on the next succeeding Business Day, (ii) if sent by a nationally recognized overnight
courier, upon receipt from such courier and (iii) if sent by U.S. mail (certified or registered
mail, return receipt requested, postage prepaid), upon receipt of such mail, addressed as follows:

If to the Company:

Ener1, Inc.

1540 Broadway, Suite 25C

New York, NY 10036

Attn: General Counsel

Tel: (212) 920-3500

Fax: (212) 920-3510 

With a copy (which shall not constitute notice) to:

Mazzeo Song & Bradham LLP

708 Third Avenue

New York, NY 10017

Attn: David S. Song

Tel: (212) 599-0700

Fax: (212) 599-8400

and if to the Investor, to such address for the Investor as shall appear opposite the Investor’s
name on Exhibit A, or as shall be designated by the Investor in writing to the Company in
accordance with this Section 6.7.

6.8 Expenses. The Company and the Investor shall pay all costs and expenses that it
incurs in connection with the negotiation, execution, delivery and performance of this Agreement.

6.9 Entire Agreement; Amendments. This Agreement constitutes the entire agreement
between the parties with regard to the subject matter hereof and thereof, superseding all prior
agreements or understandings, whether written or oral, between or among the parties. Except as
expressly provided herein, none of the provisions of this Agreement may be amended or waived except
pursuant to a written instrument executed by the Company and the Investor. Any waiver or consent
shall be effective only in the specific instance and for the specific purpose for which it was
given.

[Signature Pages to Follow]

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date
first-above written.

ENER1, INC.

	 	 	 	 	 
	By:	 	_______________________________
Name:

	 	 	 	 	Title:

ITOCHU CORPORATION

	 	 	 	 	 
	By:	 	_______________________________
Name:

	 	 	 	 	Title:

1

Exhibit A

	 	 	 	 	 
	Investor

	 	Notice Information
	 	Shares Purchased
	 

	 	 
	 	 
	ITOCHU Corporation

TOKVU Section

	 	 	 	US$20,000,000

3,236,246 Shares
	
 
	 	 	 	 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]